Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ambros IM, Zellner A, Roald B, Amann G, Ladenstein R, Printz D et al. (1996) Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 334:1505–1511
Ambros IM, Attarbaschi A, Rumpler S, Luegmayr A, Turkof E, Gadner H, Ambros PF (2001) Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med Pediatr Oncol 36:163–168
Ambros IM, Hata J-I, Joshi VV, Roald B, Dehner LP, Tuchler H, Potschger U, Shimada H (2002) Morphologic features of neuroblastoma (Schwannian stroma poor tumors) in clinically favorable and unfavorable groups. Cancer 94:1574–1583
Beckwith JB, Martin RF (1968) Observations on the histopathology of neuroblastomas. J Pediatr Surg 3:106–110
Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams and Wilkins, Philadelphia, pp 895–938
Bursch W, Liehr JG, Sirbasku DA, Putz B, Taper H, Schulte-Hermann R (1991) Control of cell death (apoptosis) by diethyl-stilbestrol in an estrogen-dependent kidney tumor. Carcinogenesis 12:855–860
Dehner LP (1988) Classic neuroblastoma: histopathologic grading as a prognostic indicator: the Shimada system and its progenitors. Am J Pediatr Hematol Oncol 10:143–154
Goto S, Umehara S, Gebing RB, Stram DO, Brodeur GM, Seeger RC et al. (2001) Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. A report from the Children's Cancer Group. Cancer 92:2699–2708
Gross RE, Farber S, Martin LW (1959) Neuroblastoma sympatheticum, a study and report of 217 cases. Pediatrics 23:1179–1191
Hughes M, Marsden HB, Palmer MK (1974) Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706–1711
Joshi VV, Cantor AB, Altshuler A, Larkin EW, Neill JSA, Shuster JJ et al. (1992) Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: a clinical pathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197–2211
Joshi VV, Rao PV, Canter AB, Altshuler G, Shuster JJ, Castleberry RP (1996) Modified histologic grading of neuroblastoma by replacement of mitotic rate with mitosis karyprrhexis index: a clinicopathologic study of 223 cases from the Pediatric Oncology Group. Cancer 77:1582–1588
Landau M (1911) Verhandlungen des Internationalen Pathologischen Kongresses, Turin
Mäkinen J (1972) Microscopic patterns as guide to prognosis of neuroblastoma in childhood. Cancer 29:1637–1646
Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, Chi S, Ladanyi M, Cordon-Cardo C, Gerald WL (2001) Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res 61:6892–6898
Peuchmaur M, d'Amore ESG, Joshi VV, Hata J, Roald B, Dehner LP et al. (2003) Revision of the International Neuroblastoma Pathology Classification: Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98:2274–2281
Reynolds ML, Woolf CJ (1993) Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 3:683–693
Ross JA, Severson RK, Pollock BH, Robison LL (1996) Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trial groups. Cancer 77:201–207
Schmidt ML, Salwen HR, Chagnovich D, Bauer KD, Crawford SE, Cohn SL (1993) Evidence for molecular heterogeneity in human ganglioneuroblastoma. Pediatr Pathol 13:787–796
Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T et al. (1984) Histopathologic prognostic factors in neuroblastic tumors; definition of subtypes of ganglioneuro-blastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405–416
Shimada H, Aoyama C, Chiba T, Newton WA Jr (1985) Prognostic subgroups for undifferentiated neuroblastoma: immunohistochemical study with anti-S-100 protein antibody. Hum Pathol 16:471–476
Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999a) Terminology and morphologic criteria of neuroblastic tumors: recommendation by the International Neuroblastoma Pathology Committee. Cancer 86:349–363
Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B et al. (1999b) The International Neuroblastoma Pathology Classification (Shimada System). Cancer 86:364–372
Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM et al. (1995) Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 87:1470–1476
Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al. (2001) International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92:2451–2461
Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN et al. (2004) TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance. Cancer 101:1873–1881
Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO et al. (2000) Histopathology defines prognostic subsets of gang lioneuroblastoma, nodular: a report from the Children's Cancer Group. Cancer 89:1150–1161
Wahl HR (1914) Neuroblastomata; with a study of a case illustrating the three types that arise from the sympathetic system. J Med Res 30:205–260
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Shimada, H., Ambros, I.M. (2005). Pathology of Peripheral Neuroblastic Tumors. In: Cheung, NK.V., Cohn, S.L. (eds) Neuroblastoma. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26616-X_8
Download citation
DOI: https://doi.org/10.1007/3-540-26616-X_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40841-3
Online ISBN: 978-3-540-26616-7
eBook Packages: MedicineMedicine (R0)